Biolase (DE:BTH0)
FRANKFURT:BTH0
Holding DE:BTH0?
Track your performance easily

Biolase (BTH0) Income Statement

1 Followers

Biolase Income Statement

Last quarter (Q1 2023), Biolase's total revenue was $10.47M, an increase of 2.96% from the same quarter last year. In Q1, Biolase's net income was $-5.85M. See Biolase’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 48.76M$ 48.46M$ 39.19M$ 22.78M$ 37.80M$ 46.16M
Cost of Revenue
$ 13.33M$ -32.55M$ 22.66M$ 16.61M$ 23.51M$ 29.26M
Gross Profit
$ 14.52M$ 15.91M$ 16.53M$ 6.17M$ 14.29M$ 16.89M
Operating Expense
$ 16.90M$ -41.25M$ 32.65M$ 24.71M$ 29.91M$ 35.09M
Operating Income
$ -25.99M$ -25.12M$ -16.12M$ -18.54M$ -15.62M$ -18.20M
Net Non Operating Interest Income Expense
$ -2.89M$ -2.75M$ -2.22M$ -2.36M$ -2.16M$ -510.00K
Other Income Expense
$ -432.00K-$ 2.25M$ 4.19M$ -121.00K$ -2.74M
Pretax Income
$ -29.61M$ -28.52M$ -16.09M$ -16.70M$ -17.90M$ -21.45M
Tax Provision
$ 93.00K$ 109.00K$ 65.00K$ 128.00K$ -44.00K$ 63.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.27M$ -28.42M$ -16.70M$ -34.21M$ -17.86M$ -21.52M
Basic EPS
$ -0.91-$ -2.75$ -14.00--
Diluted EPS
$ -0.91-$ -2.75$ -14.00--
Basic Average Shares
$ 6.19M-$ 5.91M$ 2.45M--
Diluted Average Shares
$ 6.19M-$ 5.91M$ 2.45M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 30.23M$ -73.80M$ 55.30M$ 41.32M$ 53.42M$ 64.36M
Net Income From Continuing And Discontinued Operation
$ -29.27M$ -28.42M$ -16.16M$ -16.83M$ -17.86M$ -21.52M
Normalized Income
$ -13.61M-$ -17.80M$ -16.81M$ -17.73M$ -19.51M
Interest Expense
$ 854.00K-$ 2.22M$ 2.36M$ 2.16M$ 510.00K
EBIT
$ -26.72M$ -25.78M$ -13.87M$ -14.34M$ -15.74M$ -20.94M
EBITDA
$ -26.27M$ -24.08M$ -13.47M$ -13.84M$ -14.76M$ -20.00M
Currency in USD

Biolase Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis